PFNX In Development Pact For Macular Degeneration Drug; KYTH Acquires Worldwide Rights To Potential Novel Treatment Of Hair Loss
February 11, 2015 at 07:05 AM EST
Pfenex Inc. In Development Pact For Macular Degeneration Drug, KYTHERA Acquires Worldwide Rights to Potential Novel Treatment of Hair Loss
